1. Research Funding
  2. Division of Discovery Science & Technology (Bioengineering)

Division of Discovery Science & Technology (Bioengineering)

This division supports the development of biomedical technologies (without preference for any disease or application) that directly interface with human physiology and control biological function to establish next-generation interventions for human health. This division also supports research to advance the design and deployment of future technology-driven interventions.

Program Area: Prototype Design Cluster

Mathematical Modeling

Grace C.Y. Peng, Ph.D.

Program Areas: Prototype Demonstration Cluster

Biochemical Engineering

Luisa Russell, Ph.D.

Robotic Systems

Moria Fisher Bittmann, Ph.D.

illustration synthetic biology process

David Rampulla, Ph.D.

Collaborations

An important aspect of the Institute’s mission is encouraging collaborations among the institutes and centers at NIH, other federal agencies, and the private sector.

  • Interagency Modeling and Analysis Group (IMAG) – IMAG brings together program officers across multiple federal agencies to communicate, disseminate, and plan collaborative activities and joint initiatives related to computational modeling and analysis of biomedical, biological, and behavioral systems. IMAG coordinates the Multi-scale Modeling (MSM) Consortium, see IMAG wiki.
     
  • Synthetic Biology Consortium (SBC) - The SBC is a trans-NIH effort to foster collaborations among researchers and share synthetic biology technologies to address unmet needs in biology and medicine.

Division Staff

Division Events

View All Upcoming Events

Related News

  • NIH MedTech program aims to accelerate medical devices to treat, diagnose nervous system disorders

    Science Highlights ·

    shades of blue concept image of outline of head, brain and network connections
    The National Institutes of Health has awarded research funding for seven pilot projects developing early stage, yet groundbreaking neuro-technologies. The innovative projects would enable new medical devices to diagnose and treat both acute and chronic disorders, from neuropathic pain to mental illness.

  • RNA-sensing system controls protein expression in cells based on specific cell states

    NIBIB in the News ·

    Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have developed a system that can detect a particular RNA sequence in live cells and produce a protein of interest in response. Using the technology, the team showed how they could identify specific cell types, detect and measure changes in the expression of individual genes, track transcriptional states, and control the production of proteins encoded by synthetic mRNA. Source: Broad Institute of MIT and Harvard/Science Daily

  • Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

    NIBIB in the News ·

    Biomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mouse models. While most mouse trials consider simply halting growth a success, the new treatment completely eliminated tumors in 80% of mice across several model types, including those considered the most difficult to treat. Source: Science Daily/Duke University

  • Tissue chip developments: what’s the 411?

    Science Highlights ·

    Interconnected tissue chip system, held between two gloved hands
    NIBIB-funded researchers have developed an interlinked tissue chip system that can model four mature organs in their perspective environments simultaneously. These multi-organ tissue chips could represent a new way to evaluate diseases or drugs that affect multiple different tissues.

  • New NIH MedTech program aims to accelerate medical devices to treat, diagnose nervous system disorders

    Science Highlights ·

    Shades of blue design concept image of outline of head, brain and network connections
    The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs and launched a funding solicitation in support of commercially viable, clinically focused neurotechnology solutions to diagnose and treat disorders of the nervous system.
View All News